Risk assessment tools for severe side effects after breast  radiotherapy: radiation safety through biological extended models and digital twins

Project in brief

Digital twins to advance radiotherapy safety Radiation therapy is commonly used after surgery for various types of cancer, including breast cancer. Despite protection and safety measures, radiation therapy can inadvertently expose the lung and heart to radiation, raising the risk of severe cardiac and pulmonary diseases and secondary tumours.

The EU-funded TETRIS project aims to develop and test personalised risk scores to better predict and mitigate such risks caused by radiation therapy. Researchers will calibrate radiation doses, taking into account patient-specific data from imaging, genetics and transcriptomics. To further improve radioprotection strategies, TETRIS will explore the use of digital twins or virtual replicas of individual patients for enhanced risk assessment and tailored treatment plans.

Participating countries
and Partners

ITALY

Fondazione IRCCS Istituto Nazionale dei Tumori
Politecnico di Milano

UniSR Università Vita-Salute San Raffaele 

SPAIN

Fundació Privada Institut d’Investigació Oncològica de Vall d’Hebro (VHIO)
Fundación Pública Galega de Medicina Xenómica

FRANCE

Neolys Diagnostics
AQUILAB by Coexya

SWEDEN

Region Stockholm Karolinska University Hospital

Our partners

Project objectives

The main objectives of the TETRIS project are to: